Arrange your Keratoconus Appointment Today
» Contact us today to discuss your needs
Treatments
» SimLC
» Intacs
» Keraflex
Keratoconus Corneal Cross-linking News
» Trial for Accelerated Corneal Cross Linking
Keratoconus News
FOR PATIENTS DIAGNOSED WITH KERATOCONUS
TRIAL FOR ACCELERATED CORNEAL CROSS LINKING
Corneal cross-linking is a procedure that we have been doing at the Wellington Eye Clinic since January 2007 when the UV-X device which is used for the treatment received CE approval. We were the first clinic in Ireland to offer CXL for the treatment of keratoconus.
The procedure will deliver the same total energy to the cornea as the original cross-linking for progressive keratoconus, with a reduced treatment time being the only difference.
The standard corneal cross-linking takes an hour for each eye, which involves receiving Riboflavin drops for 30 minutes and then UV-A illumination for 30 minutes. AXL takes 30 minutes in total with a 20 minute soak with Riboflavin and 10 minutes illumination with UV-A.
The AXL device already has the CE mark and is in use around the world. The study has approval from the Irish Medicines Board, and the UPMC Beacon Hospital Ethics Committee.
The Wellington Eye Clinic is doing a formal study with the manufacturer to accurately monitor outcomes. It is believed that the shorter treatment time will deliver the same efficacy with a great safety margin and better patient comfort than the current CXL procedure.
This is an exciting time for the Wellington Eye Clinic and we expect the outcome of the study to be very positive for the future of Corneal Cross-Linking.
If you want to know more about Accelerated Cross-Linking, or would like to discuss with one of our clinicians please contact us on info@wellingtoneyeclinic.com, or call us on +353 - 1 - 2930470.
NOMINATION FOR HEALTH AWARD
Dr Arthur Cummings was recently nominated as a finalist for the 2011 Innovation Healthcare Awards held at the Burlington Hotel.
Dr Cummings had been nominated for his invention SimLC which is a treatment for a disease called keratoconus.
Keratoconus causes a steepening of the eyes cornea which can significantly reduce the quality of vision and lead to blindness.
SimLC is a new methodology which combines a technique called Corneal Cross Linking and excimer laser technology. Excimer laser technology is the technology used to correct patients vision to eliminate the need for glasses and contact lens. It not only stops the progression of keratoconus in 100% of cases, but in 70% of cases actually leads to an improvement patients vision.
KERATOCONUS SUPPORT GROUP
The Global Keratoconus Society is a unique global alliance of experts representing patients of all nationalities across all stages of vision and promoting patient-centred healthcare around the world.
For more details visit www.kcglobal.org The organization is based in London and represents a valuable and open information forum.
MASTER STUDY PROGRAM
Rebecca McQuaid, Ophthalmic Technician and research assistant is presently undertaking a Masters Degree sponsored by the Wellington Eye Clinic in Physics and Cornea Diagnostics at University College Dublin.
The thesis will evaluate the different collagen lamella structures in the cornea through Second Harmonic Imaging under certain intensities of UV Light during Corneal Cross-Linking for keratoconus.
The research project aims to reduce treatment time of Corneal Cross-Linking whilst proving it a safe and effective method to stop the progression of keratoconus.
The project is under the auspices of Dr. Brian Vohnsen, head of Advanced Optical Imaging UCD, and JiaJun Li, Phd student.
Rebecca attended the annual Corneal Cross-Linking (CXL) conference Milan and is preparing a presentation for last years meeting. She is actively working with other experts internationally in the field such as Professor Michael Mrochen in Zurich, Switzerland, Dr. Prema Padmanabhan in Chennai, India.
